Christopher Parker
Net worth: 20 460 $ as of 29/04/2024
Profile
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd.
from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd.
from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANTEOTECH LTD
0.06% | 26/06/2023 | 1,500,000 ( 0.06% ) | 20 460 $ | 29/04/2024 |
Former positions of Christopher Parker
| Companies | Position | End |
|---|---|---|
| ANTEOTECH LIMITED | Chief Executive Officer | 30/11/2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Corporate Officer/Principal | 30/06/2017 |
Training of Christopher Parker
| Queensland University of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANTEOTECH LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Christopher Parker
